Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study
Open Access
- 9 January 2018
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 118 (4) , 611-615
Abstract
Increasing data suggest that aspirin use may improve cancer survival; however, the evidence is sparse for ovarian cancer. We examined the association between postdiagnosis use of low-dose aspirin and mortality in a nationwide cohort of women with epithelial ovarian cancer between 2000 and 2012. Information on filled prescriptions of low-dose aspirin, dates and causes of death, and potential confounding factors was obtained from nationwide Danish registries. We used Cox regression models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) for ovarian cancer-specific or other-cause mortality associated with low-dose aspirin use. Among 4117 patients, postdiagnosis use of low-dose aspirin was associated with HRs of 1.02 (95% CI: 0.87–1.20) for ovarian cancer mortality and 1.06 (95% CI: 0.77–1.47) for other-cause mortality. Hazard ratios remained neutral according to patterns of low-dose aspirin use, including prediagnosis use or established mortality predictors. Low-dose aspirin use did not reduce mortality among ovarian cancer patients.Keywords
This publication has 22 references indexed in Scilit:
- Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survivalCancer Epidemiology, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012Clinical Epidemiology, 2014
- Threats to Validity of Nonrandomized Studies of Postdiagnosis Exposures on Cancer Recurrence and SurvivalJNCI: Journal of the National Cancer Institute, 2013
- The role of aspirin in cancer preventionNature Reviews Clinical Oncology, 2012
- Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2010
- Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999